3654 results for «308»
3654 results
!!!NEWSFLASH!!! Long-term outcomes of the TAVI low risk trials - from headlines to clinical practice
20 Nov 2023 – From PCR London Valves 2023
Join this session to navigate through the long-term outcomes of TAVI low-risk trials (Partner 3, Evolut Low Risk...), to enhance your ability to synthesize and interpret clinical evidence and to learn how to seamlessly integrate these insights into your Heart Team's daily clinical practice.
TAVI with a new generation of valve and difficult arterial access - LIVE case
07 Dec 2023 – From GulfPCR-GIM 2023
An 84-year-old woman with type 2 diabetes, anaemia (Hgb: 9 g/dl), morbid obesity and limited mobility, and mild LV function impairment (50%), presented an acute heart failure on severe aortic valve stenosis.
The operators decided to implant an Evolut FX by femoral access with secondary access in...
Lifetime management - Tailoring treatment options to secure future possibilities
07 Dec 2023 – From GulfPCR-GIM 2023
Discover key insights in this video session from GulfPCR-GIM 2023 focusing on post-TAVI considerations. Gain understanding into the importance of posterior left ventricular and conduction disorders after TAVI and their impact on long-term outcomes. Explore the latest evidence regarding lifetime management for aortic stenosis patients. Delve...
Left main stenting: one vs. two stent strategy
06 Dec 2023 – From GulfPCR-GIM 2023
In these selected clinical cases, discover strategies on whether to choose one or two stents in the case of left main disease. Explore the use of effective imaging, IABP, and other mechanical support devices.
Challenging cases – Best case submissions
07 Dec 2023 – From GulfPCR-GIM 2023
Explore catheter intervention for mechanical valve thrombosis, understand severe chest pain and shock in a young female patient, discover iatrogenic left main coronary artery type F dissection, address refractory ascites transitioning from internal medicine to interventional cardiology, and witness a narrowly avoided rotablation nightmare in this...
GulfPCR-GIM 2023 Closing Ceremony
07 Dec 2023 – From GulfPCR-GIM 2023
There is no better way to close this 2023 edition of GulfPCR-GIM than to start by thanking the clinical case and abstract authors for their submissions, before revealing the best ones and rewarding the winners. Then it's time to review this year's event by presenting the key...
Tailored approaches to complex bifurcation PCI: part 1
06 Dec 2023 – From GulfPCR-GIM 2023
This session focuses on PCI approaches to complex bifurcation. Learn more about the use of TAP technique, provisional stenting in a trifurcation, and complex multivessel PCI through the lens of a selection of cases.
Rapid-fire - Nightmares in the cathlab - Part 3
21 Nov 2023 – From PCR London Valves 2023
Consult this session to uncover challenging scenarios: navigate the complications of balloon-expanding TAVI embolization triggered by a Starr Edwards valve in the mitral position, delve into the nightmare of an embolic stroke post-TAVI in a patient with a porcelain aorta, explore the complexities of TAVR following two...
Prognostic significance of thermodilution-derived coronary flow capacity in patients with deferred revascularisation
15 Mar 2021
The aim of this study was to investigate the prognostic value of thermodilution-derived coronary flow capacity (T-CFC) in patients with stable coronary artery disease and deferred revascularisation.
Authors :
Jupiter Endovascular announces positive results from SPIRARE I first-in-human study presented at TCT 2025
26 Oct 2025
Primary left ventricular unloading in anterior STEMI without cardiogenic shock: Results from the STEMI-Door to Unload randomized clinical trial
28 Mar 2026
Elad Asher provides his take on the STEMI-DTU trial, which was presented by Navin K. Kapur at the ACC.26 in New Orleans, and simultaneously published in the JACC.
Author
FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE coronary intravascular lithotripsy catheter meets primary safety and effectiveness endpoints
18 May 2026
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
02 Sep 2025
Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...
Author
